# A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

> **NCT05133440** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Radium dichloride
- **DIAGNOSTIC_TEST:** PET Scan

## Key facts

- **NCT ID:** NCT05133440
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-12
- **Primary completion:** 2026-04-27
- **Final completion:** 2026-04-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05133440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05133440, "A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05133440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*